Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02476968
Title	To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian Cancer (ORZORA)
Acronym	ORZORA
Recruitment	Completed
Gender	female
Phase	FDA approved
Variant Requirements	Yes
Sponsors	AstraZeneca
Indications	fallopian tube cancer peritoneum cancer ovarian cancer
Therapies	Olaparib
Age Groups:	senior \| adult
Covered Countries	POL \| ITA \| HUN \| GBR \| ESP \| CZE \| CAN \| BGR